VERIFIEDMint Markets·1 Jul 2026neutral

Aurobindo Pharma’s investors await next leg of growth

AI Summary

·Aurobindo Pharma's growth is expected to be supported by the Pen-G project ramp-up.
·Integration of Lannett and new US product launches are anticipated to aid growth.
·Expansion in Europe and contributions from higher-margin businesses are also expected to drive growth.